What's breaking now, across thousands of outlets.
Acute myeloid leukemia (AML) is an aggressive blood cancer that remains difficult to treat. While targeted therapies have improved outcomes for some patients, many relapse when a small population of cancer stem cells survives treatment and seeds the disease again.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
Union Health Minister J.P. Nadda said TB case notification has increased over the past three years, helping bridge the gap in “missing” cases
The FDA warns that regenerative medicine is being marketed to treat a wide range of conditions before it has been authorized.
Eastern Mediterranean Regional Director Dr Hanan Balkhy will take immediate leave effective Tuesday to formally launch her campaign in the WHO Director-General Election, according to an internal…
Labeling people with Long COVID as “patients” is stigmatizing and personally and politically harmful. It strips personal agency. And frankly, it’s bad PR. The post There’s a long history of person-first language in advocacy. Here’s why we should use it for Long COVID. first appeared on The Sick Times .
We would like to hear your experience of using peptides for therapeutic purposes In recent years there has been a boom in interest in using peptides , from weight loss to anti-ageing and recovery from injury. These include approved prescription weight-loss medications based on synthetic peptides that mimic natural hormones.
(MedPage Today) -- The proportion of new buprenorphine prescriptions for opioid use disorder (OUD) that were never dispensed or filled increased from 2020 to 2024, according to a retrospective cohort study. Among over 1,400 patients with commercial...
